The Luxembourgish non-profit association Plooschter Projet renews its financial support to leukemia research and funds a project from the TSI group of the LIH’s Department of Oncology, aiming to characterise in detail the identity and features of cells from the tumour microenvironment in chronic lymphocytic leukaemia.

The Luxembourg National Research Fund (FNR) supports multi-annual thematic research programmes with its central funding instrument CORE. One research project submitted by LIH and another two developed in partnership with the Luxembourg Institute for Socio-Economic Research (LISER) and the University of Luxembourg, respectively, have been selected for this valuable third party funding by international expert committees. They shall start in early 2020.

In 2019 the LIH established the Quantitative biology unit (QBU). The QBU conducts research in different technology-driven areas and provides technology services for the LIH and the Luxembourgish research community. The QBU is involved in many multi-omics studies with LIH or research groups from other Luxembourgish partners centered on cancer, immunologic and infectious diseases. Therefore, a wide range of technologies are used including next-generation RNA and DNA sequencing, metabolomics, discovery and targeted proteomics, cytometric and mass-cytometric analysis on a single-cell basis.

Lecture Series Cancer Research - "MANIPULATING INFLAMMATION TO RAISE CANCER IMMUNOGENICITY"- Dr Santiago Zelenay

LOVIT is seeking a highly motivated Postdoctoral Fellowto work in the development of secondgeneration parvovirus based therapies in Luxembourg City. The candidatewill join a team of very motivated scientists in a stimulating environmentparticipating in a very promising established project.

Lecture Series Cancer Research - "EXPLORING AND EXPLOITING THE TUMOR MICROENVIRONMENT"- Prof Johanna JOYCE

The GLASS Consortium, involving Prof Simone P. Niclou from LIH, aims to characterise diffuse glioma cells both before and after therapy to find out how they change and why this form of malignant brain cancer is so difficult to treat. Initial findings published in Nature in November 2019 provide a foundation for further research and the opportunity for the clinical community to predict the effectiveness of newly developed treatments.

Lecture series Infection & Immunity: "MAPPING NUTRIENT UTILIZATION BY T CELLS IN VIVO: IMPLICATIONS FOR IMMUNITY" - Prof Russell Jones

A team of researchers from the Molecular and Translational Allergology group at the LIH’s Department of Infection and Immunity were recently awarded a series of prizes in recognition of their high-impact research during the 8th International Symposium on Molecular Allergology (ISMA) in Amsterdam and at the Allergy School on Food Allergy in Paris.